Cargando…

Comparison of the efficacy and safety of Rituximab (Mabthera™) and its biosimilar (Reditux™) in diffuse large B-cell lymphoma patients treated with chemo-immunotherapy: A retrospective analysis

BACKGROUND: Rituximab (Mabthera™) have been in use in India since 2000. A biosimilar molecule of rituximab (Reditux™) was approved in India in 2007. This retrospective audit was done to compare the efficacy and safety of Mabthera™ with Reditux™. MATERIALS AND METHODS: We reviewed the charts of 223 a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roy, Partha Sarathi, John, Shiji, Karankal, Sadashiv, Kannan, Sadhana, Pawaskar, Preeti, Gawande, Jayanta, Bagal, Bhausaheb, Khattry, Navin, Sengar, Manju, Menon, Hari, Gujral, Sumeet, Nair, Reena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932598/ https://www.ncbi.nlm.nih.gov/pubmed/24604960 http://dx.doi.org/10.4103/0971-5851.125248

Ejemplares similares

P454: ACUTE MYELOID LEUKEMIA (AML) WITH IDH1 AND IDH2 MUTATIONS CAN BE EFFECTIVELY RISK STRATIFIED BASED ON THE PRESENCE ADVERSE RISK GENOMIC FEATURES.
por: Bhide, Aniket, et al.
Publicado: (2023)

Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy
por: Tembhare, Prashant Ramesh, et al.
Publicado: (2020)

Role of cytogenetic abnormalities detected by fluorescence in situ hybridization as a prognostic marker: Pathogenesis & clinical course in patients with B-chronic lymphocytic leukaemia
por: Shetty, Dhanlaxmi, et al.
Publicado: (2021)

Real-World Outcomes With Generic Pomalidomide in Relapsed Refractory Multiple Myeloma—Experience From a Tertiary Care Cancer Center
por: Bondili, Suresh Kumar, et al.
Publicado: (2021)

Physicochemical and functional assessments demonstrating analytical similarity between rituximab biosimilar HLX01 and the MabThera®
por: Xu, Yanpeng, et al.
Publicado: (2019)

Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia
por: Patkar, Nikhil, et al.
Publicado: (2018)

Correction: Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia
por: Patkar, Nikhil, et al.
Publicado: (2019)

A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1
por: Patkar, Nikhil, et al.
Publicado: (2019)

P360: MEASURABLE/MINIMAL RESIDUAL DISEASE (MRD) STATUS IS THE MOST RELEVANT INDICATOR OF CLINICAL OUTCOME IN MIXED PHENOTYPIC ACUTE LEUKEMIAS (MPAL)
por: Tembhare, Prashant, et al.
Publicado: (2023)

Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia—Real-World Context
por: Patkar, Nikhil, et al.
Publicado: (2019)

Sequential Treatment of Arsenic Trioxide Followed by All Trans Retinoic Acid with Anthracyclines has Excellent Long-Term Cure in Acute Promyelocytic Leukemia
por: Devadas, Santhosh Kumar, et al.
Publicado: (2020)

NARASIMHA: Novel Assay based on Targeted RNA Sequencing to Identify ChiMeric Gene Fusions in Hematological Malignancies
por: Patkar, Nikhil, et al.
Publicado: (2020)

Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)
por: Patkar, Nikhil, et al.
Publicado: (2021)

Machine learning derived genomics driven prognostication for acute myeloid leukemia with RUNX1-RUNX1T1
por: Shaikh, Anam Fatima, et al.
Publicado: (2020)

Study of stem cell homing & self-renewal marker gene profile of ex vivo expanded human CD34(+) cells manipulated with a mixture of cytokines & stromal cell-derived factor 1
por: Kode, Jyoti, et al.
Publicado: (2017)

Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase
por: Shpilberg, O, et al.
Publicado: (2013)

Role of Curcumin in Reducing Toxicities Associated With Mucosal Injury Following Melphalan-Based Conditioning in Autologous Transplant Setting
por: Punatar, Sachin, et al.
Publicado: (2022)

P003: A retrospective study to evaluate the reliability of staging and risk stratification of adolescent and adult patients with Hodgkin’s lymphoma registered in the lymphoma clinic at Tata Memorial Centre.
por: Jain, Hasmukh, et al.
Publicado: (2022)

Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar era
por: Nair, Reena, et al.
Publicado: (2023)

Splenic marginal zone lymphoma relapsing as miliary lung mottling: an unusual presentation
por: Mandal, Tanmoy, et al.
Publicado: (2018)

The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies
por: Vander Cruyssen, Bert, et al.
Publicado: (2010)

A Limited Sampling Strategy for Therapeutic Drug Monitoring of Mycophenolate Mofetil for Prophylaxis of Acute Graft-Versus-Host Disease in Allogeneic Stem Cell Transplantation
por: Gota, Vikram, et al.
Publicado: (2020)

Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin’s Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in India
por: Tembhare, Prashant R., et al.
Publicado: (2022)

A Prospective Survey to Understand the Preferences and Perspectives of Patients with Hematological Malignancies in a Tertiary Cancer Care Setting in India (CANCOV SURVEY)
por: Sharma, Dr. Neha, et al.
Publicado: (2021)

Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India
por: Kadam Amare, Pratibha S., et al.
Publicado: (2016)

Infection Prevalence in Adolescents and Adults With Acute Myeloid Leukemia Treated in an Indian Tertiary Care Center
por: Jain, Hasmukh, et al.
Publicado: (2020)

Randomized, Double-Blind, Pharmacokinetic Equivalence Trial Comparing DRL-Rituximab With MabThera in Patients With Diffuse Large B-Cell Lymphoma
por: Viswabandya, Auro, et al.
Publicado: (2019)

A Randomized, Double-Blind, Efficacy and Safety Study of PF-05280586 (a Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera(®)) in Subjects with Previously Untreated CD20-Positive, Low-Tumor-Burden Follicular Lymphoma (LTB-FL)
por: Sharman, Jeff P., et al.
Publicado: (2019)

Summary of the published Indian data on chronic myeloid leukemia
por: Singhal, Manish K., et al.
Publicado: (2016)

Introduction of Situation, Background, Assessment, Recommendation into Nursing Practice: A Prospective Study
por: Achrekar, Meera S., et al.
Publicado: (2016)

Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax
por: Gaur, Tarang, et al.
Publicado: (2023)

A Double-Blind, Randomized Comparison Study between Zytux™ vs MabThera® in Treatment of CLL with FCR Regimen: Non-Inferiority Clinical Trial
por: Toogeh, Gholamreza, et al.
Publicado: (2018)

Current status of hematopoietic stem cell transplant in chronic myeloid leukemia
por: Gupta, Alok, et al.
Publicado: (2014)

A retrospective audit of clinicopathological attributes and treatment outcomes of adolescent and young adult non-Hodgkin lymphomas from a tertiary care center
por: Sengar, Manju, et al.
Publicado: (2011)

COVID‐19 in cancer patients on active systemic therapy – Outcomes from LMIC scenario with an emphasis on need for active treatment
por: Ramaswamy, Anant, et al.
Publicado: (2020)

Editorial: Real World Outcomes of Lymphoma From India
por: Kumar, Lalit, et al.
Publicado: (2022)

Biosimilars
por: Martin, Miguel
Publicado: (2018)

Therapeutic drug monitoring for imatinib: Current status and Indian experience
por: Arora, Brijesh, et al.
Publicado: (2013)

Targeting transcriptional kinase of CDK7 halts proliferation of multiple myeloma cells by modulating the function of canonical NF-kB pathway and cell cycle regulatory proteins
por: Dutta, Rudra Prasad, et al.
Publicado: (2023)

Dynamics of viral RNA load, virus culture, seroconversion & infectivity in COVID-19 patients: Implications on isolation policy
por: Bhat, Vivek, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5sl7g6ff4f6dhpb95j9k5q6mrd